Synopsis
Fixed energy minifocus beamline
Status:
open
Disciplines
Applications
- MASSIF-3 is a minifocus beamline (15 µm diameter), operating at fixed energy (12.81 keV). The beamline is dedicated to protein crystals of small size, inhomogeneous protein crystals, and fast data collection, and is also suitable for SAD measurements (Se, Pt, Au,...). MASSIF-3 is equipped with a MD2 micro-diffractometer and with a FlexHCD sample changer for SPINE pucks and UniPucks. Diffraction data are recorded on a Eiger1 X 4M detector that allows data collection at a very high frame rate (up to 750 Hz). The high resolution limit on the beamline is 1.17 Å.
Techniques
-
Anomalous diffraction
-
MX - macromolecular crystallography
-
Microbeam
-
Microcrystallography
-
Optical spectroscopy
-
Single-crystal diffraction
-
XRD - X-ray diffraction
Beam size
- Minimum (H x V) : 15.0
x 15.0
µm²
-
Maximum (H x V) : 15.0
x 15.0
µm²
Sample environments
- 100 K cryostream
- automatic sample changer
- dehydration device
- online microspec
Detectors
Technical details
High resolution limit - 1.17Å
References:
ID30A-3 (MASSIF-3) – a beamline for macromolecular crystallography at the ESRF with a small intense beam, D. Von Stetten et al., J. Synchrotron Radiat. (2020) 27: 844–851. doi: 10.1107/S1600577520004002
The Upgrade Programme for the Structural Biology beamlines at the European Synchrotron Radiation Facility – High throughput sample evaluation and automation, P. Theveneau et al. (2013) J. Phys.: Conf. Ser. 425 012001 doi:10.1088/1742-6596/425/1/012001
Add this RSS feed to your favorite RSS reader (Thunderbird, Outlook etc...) or install an add-on to your browser, such as RSSPreview for Firefox
PrgE: an OB-fold protein from plasmid pCF10 with striking differences to prototypical bacterial SSBs
Breidenstein A., Lamy A., Bader C.P.J., Sun W.S., Wanrooij P.H., Berntsson R.P.A.,
Life Science Alliance 7, e202402693-1-e202402693-14 (2024)
Bdellovibrio bacteriovorus uses chimeric fibre proteins to recognize and invade a broad range of bacterial hosts
Caulton S.G., Lambert C., Tyson J., Radford P., Al-Bayati A., Greenwood S., Banks E.J., Clark C., Till R., Pires E., Sockett R.E., Lovering A.L.,
Nature Microbiology 9, 214-22725 (2024)
Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitors
Cervi G., D'Alessio R., Bindi S., Buffa L., Burocchi A., Canevari G., Modugno M., Motto I., Saturno G., Orsini P.,
European Journal of Medicinal Chemistry 270, 116375-1-116375-17 (2024)
Exploring the pH dependence of an improved PETase
Charlier C., Gavalda S., Grga J., Perrot L., Gabrielli V., Löhr F., Schörghuber J., Lichtenecker R., Arnal G., Marty A., Tournier V., Lippens G.,
Biophysical Journal 123, 1542-1552 (2024)
Interactions of phenylalanine derivatives with human tyrosinase: lessons from experimental and theoretical tudies
Faure C., Ng Y.M., Belle C., Soler-López M., Khettabi L., Saïdi Me., Berthet N., Maresca M., Philouze C., Rachidi W., Réglier M., d'Hardemare A.D., Jamet H.,
ChemBioChem 25, e202400235-1-e202400235-18 (2024)
A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties
Laghezza A., Cerchia C., Genovese M., Montanari R., Capelli D., Wackerlig J., Simic S., Falbo E., Pecora L., Leuci R., Brunetti L., Piemontese L., Tortorella P., Biswas A., Singh R.P., Tambe S., Sudeep C.A., Pattnaik A.K., Jayaprakash V., Paoli P., Lavecchia A., Loiodice F.,
European Journal of Medicinal Chemistry 275, 116567-1-116567-22 (2024)